ArticleThe Journal of pharmacology and experimental therapeutics2013

Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.

Steven G Kinsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.